AKTion on mantle cell lymphoma
Michael R. Gold
Abstract
Open-access reader
Michael R. Gold
Abstract
Open-access reader
Patients with mantle cell lymphoma (MCL) generally have a poor prognosis.Rudelius and colleagues now show that the PI 3-kinase/Akt prosurvival signaling pathway is constitutively activated in the more aggressive blastoid form of MCL and that inhibitory drugs targeting this pathway promote the apoptosis of MCL cells, raising the possibility of new treatments for blastoid MCL.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Patients with mantle cell lymphoma (MCL) generally have a poor prognosis.Rudelius and colleagues now show that the PI 3-kinase/Akt prosurvival signaling pathway is constitutively activated in the more aggressive blastoid form of MCL and that inhibitory drugs targeting this pathway promote the apoptosis of MCL cells, raising the possibility of new treatments for blastoid MCL.
Key concepts: Blastoid, Mantle cell lymphoma, Cancer research, Lymphoma, Protein kinase B, Medicine, Signal transduction, Biology